X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
danaparoid sodium (92) 92
humans (72) 72
danaparoid (59) 59
heparin (51) 51
heparin - adverse effects (46) 46
heparin-induced thrombocytopenia (46) 46
thrombocytopenia (41) 41
thrombocytopenia - chemically induced (40) 40
thrombosis (39) 39
male (38) 38
anticoagulants - adverse effects (31) 31
molecular-weight heparin (30) 30
anticoagulants - therapeutic use (28) 28
cardiopulmonary bypass (28) 28
female (28) 28
anticoagulation (27) 27
recombinant hirudin (23) 23
argatroban (22) 22
chondroitin sulfates - therapeutic use (22) 22
dermatan sulfate - therapeutic use (22) 22
hematology (22) 22
heparitin sulfate - therapeutic use (22) 22
index medicus (21) 21
lepirudin (21) 21
anticoagulants (19) 19
unfractionated heparin (19) 19
antibodies (18) 18
middle aged (18) 18
risk factors (18) 18
aged (16) 16
drug combinations (16) 16
peripheral vascular disease (16) 16
pregnancy (16) 16
animals (15) 15
anticoagulants - administration & dosage (15) 15
diagnosis (15) 15
adult (14) 14
hirudin (14) 14
medicine & public health (14) 14
org-10172 (14) 14
critical care medicine (13) 13
heparin - therapeutic use (13) 13
thrombocytopenia - drug therapy (13) 13
anesthesiology (12) 12
complications and side effects (12) 12
glycosaminoglycans (12) 12
heparin - immunology (12) 12
management (12) 12
thrombocytopenia - diagnosis (12) 12
danaparoid-sodium (11) 11
pharmacology/toxicology (11) 11
treatment outcome (11) 11
children (10) 10
chondroitin sulfates - administration & dosage (10) 10
dermatan sulfate - administration & dosage (10) 10
fibrinolytic agents - therapeutic use (10) 10
heparitin sulfate - administration & dosage (10) 10
induced thrombocytopenia (10) 10
pharmacology & pharmacy (10) 10
anticoagulants - pharmacology (9) 9
child (9) 9
dermatan sulfate (9) 9
heparan sulfate (9) 9
hit (9) 9
medicine, general & internal (9) 9
orgaran org-10172 (9) 9
recombinant proteins - therapeutic use (9) 9
thrombocytopenia - therapy (9) 9
thrombosis - drug therapy (9) 9
danaparoid-sodium, therapeutic use (8) 8
drug therapy (8) 8
liver cirrhosis (8) 8
low-molecular-weight heparin (8) 8
orgaran (8) 8
portal vein thrombosis (8) 8
sodium (8) 8
surgery (8) 8
therapy (8) 8
thrombocytopenia - complications (8) 8
venous thromboembolism (8) 8
adolescent (7) 7
aged, 80 and over (7) 7
anticoagulants - pharmacokinetics (7) 7
blood clot (7) 7
chondroitin sulfates - pharmacology (7) 7
dermatan sulfate - pharmacology (7) 7
dosage and administration (7) 7
fibrinolytic agents - adverse effects (7) 7
heparitin sulfate - pharmacology (7) 7
infant (7) 7
lepirudin, therapeutic use (7) 7
pediatrics (7) 7
portal vein (7) 7
rats (7) 7
respiratory system (7) 7
risk-factors (7) 7
bivalirudin (6) 6
cardiac & cardiovascular systems (6) 6
cardiac-surgery (6) 6
case studies (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 05/2000, Volume 1, Issue 4, pp. 803 - 814
Danaparoid sodium (Orgaran™, Organon) is a heparinoid glycosaminoglycuronan antithrombotic agent approved for the prophylaxis of post-operative deep vein... 
unfractionated heparin (UFH) | low molecular weight heparin (LMWH) | heparin-induced thrombocytopenia (HIT) | anticoagulation | anti-FXa units | danaparoid sodium (Orgaran™) | danaparoid sodium (Orgaran™) | Low molecular weight heparin (lmwh) | Danaparoid sodium (orgaran™) | Anticoagulation | Anti-fxa units | Heparin-induced thrombocytopenia (hit) | Unfractionated heparin (ufh) | Heparitin Sulfate - adverse effects | Heparitin Sulfate - economics | Anticoagulants - administration & dosage | Blood Coagulation Disorders - economics | Humans | Anticoagulants - economics | Heparitin Sulfate - therapeutic use | Fibrinolytic Agents - adverse effects | Thrombocytopenia - drug therapy | Chondroitin Sulfates - adverse effects | Fibrinolytic Agents - pharmacokinetics | Heparitin Sulfate - administration & dosage | Fibrinolytic Agents - therapeutic use | Chondroitin Sulfates - pharmacokinetics | Heparitin Sulfate - pharmacokinetics | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Anticoagulants - therapeutic use | Chondroitin Sulfates - economics | Clinical Trials as Topic | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Chondroitin Sulfates - therapeutic use | Dermatan Sulfate - economics | Chondroitin Sulfates - administration & dosage | Blood Coagulation Disorders - drug therapy | Fibrinolytic Agents - economics | Dermatan Sulfate - pharmacokinetics | Blood Coagulation Disorders - blood | Anticoagulants - pharmacokinetics | Dermatan Sulfate - therapeutic use | Fibrinolytic Agents - administration & dosage | Drug Combinations
Journal Article
Analytical and bioanalytical chemistry, ISSN 1618-2642, 01/2011, Volume 399, Issue 2, p. 629
Journal Article
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, ISSN 1618-2642, 01/2011, Volume 399, Issue 2, pp. 629 - 634
Danaparoid sodium (the active pharmaceutical ingredient in Orgaran; Merck Sharp and Dohme) is a biopolymeric non-heparin drug used as anticoagulant and... 
Heparan sulfate | CHEMISTRY, ANALYTICAL | Glycosaminoglycans | CRYSTAL-STRUCTURE | NUCLEAR-MAGNETIC-RESONANCE | BIOCHEMICAL RESEARCH METHODS | HEPARIN | H-1 NMR spectroscopy | Dermatan sulfate | Chondroitin sulfate | Danaparoid sodium | Chemometrics | LYASE | Partial least-squares regression
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 11/2002, Volume 40, Issue 5, pp. 990 - 995
Journal Article
Journal of research in pharmacy practice, ISSN 2319-9644, 04/2015, Volume 4, Issue 2, pp. 73 - 78
Thrombocytopenia is a common problem in cardiovascular surgery patients. However, heparin-induced thrombocytopenia (HIT) is a rare but life-threatening... 
Cardiac surgery | Original | danaparoid | heparin-induced thrombocytopenia | Cardiac surgery; danaparoid; heparin-induced thrombocytopenia
Journal Article
Analytical and Bioanalytical Chemistry, ISSN 1618-2642, 1/2011, Volume 399, Issue 2, pp. 629 - 634
Journal Article
Molecules, ISSN 1420-3049, 07/2017, Volume 22, Issue 7, p. 1116
Danaparoid sodium salt, is the active component of ORGARAN, an anticoagulant and antithrombotic drug constituted of three glycosaminoglycans (GAGs) obtained... 
Sequence and compositional investigations | Component quantitative analysis | Danaparoid sodium | Low molecular weight glycosaminoglycans | Orthogonal multi-analytical methods | GLYCOSAMINOGLYCANS | OLIGOSACCHARIDES | component quantitative analysis | sequence and compositional investigations | TRIPLE DETECTOR ARRAY | DEPOLYMERIZATION | CHEMISTRY, ORGANIC | DERMATAN SULFATE | orthogonal multi-analytical methods | MOLECULAR-WEIGHT HEPARINS | danaparoid sodium | SIZE-EXCLUSION CHROMATOGRAPHY | low molecular weight glycosaminoglycans | CHONDROITIN SULFATES | Anticoagulants - analysis | Molecular Weight | Magnetic Resonance Spectroscopy | Dermatan Sulfate - chemistry | Chondroitin Sulfates - chemistry | Chromatography, High Pressure Liquid | Intestinal Mucosa - chemistry | Animals | Heparitin Sulfate - chemistry | Swine | Chondroitin Sulfates - analysis | Heparitin Sulfate - analysis | Chromatography, Gel | Dermatan Sulfate - analysis | Glycosaminoglycans | Molecular weight distribution | Mucosa | Sodium salts | Sulfates | Biopolymers | Molecular weight | Complexity | Magnetic resonance spectroscopy | Depolymerization | Intestine | Spectrum analysis | Two dimensional analysis | Heparan sulfate | Spectroscopy | Disaccharides | Chromatography | Quantum phenomena | Ultraviolet radiation | Sodium | Coherence | Hexosamines | Signal processing | Chondroitin sulfate | NMR spectroscopy
Journal Article
Acta Pædiatrica, ISSN 0803-5253, 07/2001, Volume 90, Issue 7, pp. 765 - 771
We report on four children with heparin‐induced thrombocytopenia type II. In three patients, therapy with unfractionated heparin was associated with... 
danaparoid sodium | thrombosis | Antiphospholipid antibodies | children | heparin‐induced thrombocytopenia | Children | Thrombosis | Danaparoid sodium | Heparin-induced thrombocytopenia
Journal Article
Journal Article
Journal Article
Journal of Clinical Apheresis, ISSN 0733-2459, 12/2006, Volume 21, Issue 4, pp. 252 - 255
Journal Article
肝臓, ISSN 0451-4203, 2009, Volume 50, Issue 7, pp. 377 - 382
症例は75歳,女性.C型肝硬変に併発した膵尾部癌術後肺転移に対して化学療法中に肝機能悪化をきたし入院となった.腹部CTにて門脈左枝を中心に本幹から右枝におよぶ血栓形成を認め,Child-Pugh... 
門脈血栓症 | danaparoid sodium | アンチトロンビンIII製剤
Journal Article